IL-17B/IL-17RB signaling promoted the upregulation of stemness and EMT formation in gastric cancer cells treated with exogenous recombinant human IL-17B (rIL-17B) by the AKT/β-catenin pathway. Here, IL17B is linked to gastric cancer.